Markets don’t need a surprise to gap. They only need one metric to miss the story the...
October 14, 2026 BMBL’s options now price deal risk, not business risk, and the structure leaves little...
September’s 36.3% jump put the surplus on pace for $1T-plus, but how much demand vanishes when the...
October 14, 2026 Bonus Content: BioNTech’s BNT113 Missed PFS. The Options Move Is Over. A note from...
A blowout Q3, guidance raised again, and demand seen through 2028.
October 13, 2026 Bonus Content: Spinning Steel Beats Lithium When the Grid Flinches A note from our...
Supercritical CO2 turbines are reaching commercialization. The bottleneck isn't the turbine.
October 13, 2026 One remark from Singapore hit a market with no marginal buyer, and CXMT offered...
October 13, 2026 Bonus Content: LVMH Reports Monday. China’s Golden Week Signal Weakens A note from our...
The 100% drug tariff is live. J&J's U.S. manufacturing bet is why this quarter matters beyond the...